Cambrex, a small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, has unveiled changes to its management team and board of directors.   The following appointments and new positions are effective immediately:   • Robert Green has been named executive vice president and chief financial officer, succeeding Gregory Sargen, who will depart the company on January 31. Mr. Green joins from General Electric Corporation, where he began his c...